COVID-19 vaccine delivery: Prepping for challenge extraordinaire
India will have a very strategic role to play in ensuring universal access to COVID-19 vaccines. All stakeholders must step up…
Sign in / Join
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates
Browsing Category
Latest Updates
Cipla launches Nintib (Nintedanib) to treat Idiopathic Pulmonary Fibrosis
Cipla’s Nintib is priced at Rs 69 (100 mg) and Rs. 85 (150 mg) per capsule
Dr Reddy’s relaunch OTC Famotidine Tablets USP, 10 mg and 20 mg, in US
They are acid reducers that prevent and relieve heartburn associated with acid indigestion and sour stomach brought on by eating…
Zydus Cadila gets final US FDA nod for Solifenacin Succinate Tablets
There are used as a symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency in patients with…
Strides receives USFDA approval for Ethacrynic Acid Tablets
It is used to treat oedema (excess fluid held in body tissues) in adults and children
First results of Russian coronavirus vaccine trial may include data from 5,000-10,000 people
Preliminary results from the late-stage human trial of Russia’s main coronavirus vaccine candidate could include data from…
Bill & Melinda Gates Foundation and Grand Challenges Partners announce new initiatives to…
Three new Grand Challenges are being launched this week to harness innovation around emerging technologies.
BDR Pharma launches Nintenib (Nintedanib) to treat idiopathic pulmonary fibrosis in India
Nintenib is priced at Rs 750 (100 mg) and INR 900 (150 mg) for a pack of 10 tabs
DPX-COVID-19 has potential to improve duration of immune response
Frederic Ors, CEO, IMV explains why the company believes that DPX-COVID-19 has the potential to improve the duration of the immune…
Zydus Cadila gets tentative USFDA nod for Tofacitinib ER tablets
It is recommended for adult patients with moderately to severely active ulcerative colitis
